GW26-e0740 Safety and Efficacy of IntraCoronary Hypoxia-precondItioned Bone Marrow MonoNuclear Cell Administration for Acute Myocardial Infarction Patients: The CHINA-AMI Randomized Controlled Trial

GW26-e0740 Safety and Efficacy of IntraCoronary Hypoxia-precondItioned Bone Marrow MonoNuclear Cell Administration for Acute Myocardial Infarction Patients: The CHINA-AMI Randomized Controlled Trial

No differences were observed in the change of left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV) or wall motion score index (WMSI) among three groups.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-10, Vol.66 (16), p.C79-C80
Hauptverfasser: Hu, Xinyang, Huang, Xin, Yang, Qian, Wang, Lihua, Sun, Jianzhong, Zhan, Hongwei, Lin, Jianjing, Pu, Zhaoxia, Jiang, Jun, Sun, Yong, Xiang, Meixiang, Liu, Xianbao, Xie, Xiaojie, Yu, Xia, Chen, Zexin
Format: Artikel
Sprache:eng
Schlagworte:
Bone marrow
Cardiology
Cardiovascular
Heart attacks
Hypoxia
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:No differences were observed in the change of left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV) or wall motion score index (WMSI) among three groups.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.06.317